Erratum: The anti-arthritis effect of sulforaphane, an activator of Nrf2, is associated with inhibition of both B cell differentiation and the production of inflammatory cytokines (PLOS ONE (2021) 16:2 (e0245986) DOI: 10.1371/journal.pone.0245986)

  • Su Jin Moon
  • , Jooyeon Jhun
  • , Jaeyoon Ryu
  • , Ji ye Kwon
  • , Se Young Kim
  • , Kyoung Ah Jung
  • , Mi La Cho
  • , Jun Ki Min

Research output: Contribution to journalComment/debate

3 Scopus citations

Abstract

There are errors in the Funding statement. The correct Funding statement is as follows: This study was supported by a grant of the Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea (HI14C1851) and the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. NRF-2018R1A2B6007648 and 2020R1I1A1A01072520).

Original languageEnglish
Article numbere0256716
JournalPLoS ONE
Volume16
Issue number8 August
DOIs
StatePublished - Aug 2021

Bibliographical note

Publisher Copyright:
© 2021 Moon et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Fingerprint

Dive into the research topics of 'Erratum: The anti-arthritis effect of sulforaphane, an activator of Nrf2, is associated with inhibition of both B cell differentiation and the production of inflammatory cytokines (PLOS ONE (2021) 16:2 (e0245986) DOI: 10.1371/journal.pone.0245986)'. Together they form a unique fingerprint.

Cite this